drug

VIR-5500

1 story · latest Aug 5, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Astellas Pharma

Timeline

Vir reports Week 96 SOLSTICE data, ECLIPSE program fully enrolled, VIR-5500 expansion underway

Aug 5Quarterly updateVir Biotechnology, Inc.VIR-5500

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.